Literature DB >> 26694585

Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation.

Julia Böhme1,2,3, Caroline Roßnagel1, Thomas Jacobs4, Jochen Behrends1,5, Christoph Hölscher1,2, Hanna Erdmann1,2.   

Abstract

The Epstein-Barr virus-induced gene 3 (EBI3) is a member of the interleukin-12 (IL)-12) family structurally related to the subunit p40 of IL-12 and forms a heterodimer either with the p28 subunit to build IL-27 or with p35 to form IL-35. Interleukin-27 is secreted by antigen-presenting cells whereas IL-35 appears to be produced mainly by regulatory T cells and regulatory B cells but both cytokines negatively regulate inflammatory immune responses. We here analysed the function of EBI3 during infection with the intracellular parasite Trypanosoma cruzi. Compared with C57BL/6 wild-type mice, EBI3-deficient (EBI3(-/-) ) mice showed a higher parasitaemia associated with an increased mortality rate. The EBI3(-/-) mice displayed an elevated inflammatory immune response with an increased production of T helper type 1 (Th1-), Th2- and Th17-derived cytokines. The increased Th2 immune response appears to have over-ridden the otherwise protective Th1 and Th17 immune responses by the induction of arginase-1-expressing alternatively activated macrophages in these mice. Hence, neutralization of IL-4 and arginase-1 activity partially restored protective immune responses in EBI3(-/-) mice. So far, our results demonstrate that EBI3 is an essential general regulator of inflammatory immune responses in experimental Chagas disease and is required for control of T. cruzi infection by inhibiting Th2-dependent alternative macrophage activation. Further studies are needed to dissect the underlying mechanisms and clarify whether EBI3 association with IL-27 or/and IL-35 accounts for its anti-inflammatory character in parasitic disease.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  alternative macrophage activation; interleukin-27; interleukin-35; parasitic infection

Mesh:

Substances:

Year:  2016        PMID: 26694585      PMCID: PMC4754611          DOI: 10.1111/imm.12565

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

2.  IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1.

Authors:  Clemens Neufert; Christoph Becker; Stefan Wirtz; Massimo C Fantini; Benno Weigmann; Peter R Galle; Markus F Neurath
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

3.  During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.

Authors:  Malcolm S Duthie; Stuart J Kahn
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

4.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

5.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

6.  TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.

Authors:  Ritsuko Koga; Shinjiro Hamano; Hirotaka Kuwata; Koji Atarashi; Masahiro Ogawa; Hajime Hisaeda; Masahiro Yamamoto; Shizuo Akira; Kunisuke Himeno; Makoto Matsumoto; Kiyoshi Takeda
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

7.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  IL-27 inhibits the development of regulatory T cells via STAT3.

Authors:  Magdalena Huber; Vera Steinwald; Anna Guralnik; Anne Brüstle; Peter Kleemann; Christine Rosenplänter; Thomas Decker; Michael Lohoff
Journal:  Int Immunol       Date:  2007-12-21       Impact factor: 4.823

9.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors:  Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

10.  IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells.

Authors:  Wanda Niedbala; Xiao-Qing Wei; Beilei Cai; Axel J Hueber; Bernard P Leung; Iain B McInnes; Foo Y Liew
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

View more
  9 in total

Review 1.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It.

Authors:  Eva V Acosta Rodríguez; Cintia L Araujo Furlan; Facundo Fiocca Vernengo; Carolina L Montes; Adriana Gruppi
Journal:  Trends Parasitol       Date:  2019-10-10

2.  The ORMDL3 Asthma Gene Regulates ICAM1 and Has Multiple Effects on Cellular Inflammation.

Authors:  Youming Zhang; Saffron A G Willis-Owen; Sarah Spiegel; Clare M Lloyd; Miriam F Moffatt; William O C M Cookson
Journal:  Am J Respir Crit Care Med       Date:  2019-02-15       Impact factor: 21.405

3.  Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation.

Authors:  Tiago Silva Medina; Gabriela Gonçalves Oliveira; Maria Cláudia Silva; Bruna Araújo David; Grace Kelly Silva; Denise Morais Fonseca; Renata Sesti-Costa; Amanda Farage Frade; Monique Andrade Baron; Barbara Ianni; Alexandre Costa Pereira; Christophe Chevillard; Edécio Cunha-Neto; José Antonio Marin-Neto; João Santana Silva
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

Review 4.  The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease.

Authors:  Gonzalo R Acevedo; Magalí C Girard; Karina A Gómez
Journal:  Front Immunol       Date:  2018-08-24       Impact factor: 7.561

5.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy.

Authors:  Christophe Chevillard; João Paulo Silva Nunes; Amanda Farage Frade; Rafael Ribeiro Almeida; Ramendra Pati Pandey; Marilda Savóia Nascimento; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2018-12-03       Impact factor: 7.561

6.  Arginase-1 Is Responsible for IL-13-Mediated Susceptibility to Trypanosoma cruzi Infection.

Authors:  Mahin Abad Dar; Christoph Hölscher
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

7.  Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses.

Authors:  Jihyung Lee; Junyan Zhang; Young-Jun Chung; Jun Hwan Kim; Chae Min Kook; José M González-Navajas; David S Herdman; Bernd Nürnberg; Paul A Insel; Maripat Corr; Ji-Hun Mo; Ailin Tao; Kei Yasuda; Ian R Rifkin; David H Broide; Roger Sciammas; Nicholas Jg Webster; Eyal Raz
Journal:  Elife       Date:  2020-02-04       Impact factor: 8.140

8.  Whole blood transcriptome analysis in onchocerciasis.

Authors:  Ole Lagatie; Linda Batsa Debrah; Alex Y Debrah; Lieven J Stuyver
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2022-08-09

Review 9.  Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection.

Authors:  Manuel Fresno; Núria Gironès
Journal:  Front Microbiol       Date:  2018-03-01       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.